Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14433
Articles
Company
Drug
Boehringer Ingelheim’s Spevigo Approved by NMPA for Generalized Pustular Psoriasis
January 28, 2025
Drug
Cosmo Pharmaceuticals’ Lumeblue Completes Phase III Trial in China
January 28, 2025
Company
Medical Device
Acotec Scientific’s NEO-Skater Balloon Approved by NMPA for Intracranial Vessels
January 28, 2025
Company
Drug
Tracon Pharmaceuticals Provides Positive Update on Envafolimab Phase II Trial
January 28, 2025
Company
Drug
Sirnaomics Announces Interim Results for STP705 in Phase IIb Study for isSCC
January 28, 2025
Company
Drug
Henlius Biotech Initiates Phase I Trial for HLX60 in Australia
January 28, 2025
Company
Deals
China Meheco to Import and Distribute Pfizer’s Paxlovid in Mainland China
January 28, 2025
Company
Medical Device
Zylox-Tonbridge Receives NMPA Approval for ZYLOX Octoplus Vena Cava Filter
January 28, 2025
Company
Deals
Innovent Biologics Collaborates with LG Chem for Tigulixostat in China
January 28, 2025
Deals
Drug
Everest Medicines Achieves Preclinical Milestone for mRNA Rabies Vaccine
January 28, 2025
Company
Deals
Alternative Bio Completes $15M Seed Round to Advance Cancer Therapeutics
January 28, 2025
Company
Deals
Shanghai Pharmaceuticals Partners with HKSTP for Biomedicine Cultivation Program
January 28, 2025
1
2
…
1,070
1,071
1,072
1,073
1,074
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?